(T 5) Weight Loss With Atogepant Versus Topiramate: Post hoc Analysis of the Head-to-Head TEMPLE Trial

Non-presenting author(s)

Dale S. Bond, PhD

Director of Research Integration
Hartford Hospital/Hartford HealthCare
Hartford, Connecticut, United States

Peter Goadsby, PhD DSc FRACP FRCP FMedSci FRS

Professor of Neurology and Honorary Consultant Neurologist
University of Leeds UK, King Abdullah University of Science and Technology, Saudi Arabia,NIHR King’s Clinical Research Facility, & SLaM Biomedical Research Centre, and The Wolfson Sensory, Pain and Regeneration Centre (SPaRC), Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
London, United Kingdom
ST

Stewart J. Tepper, MD

Geisel Professor of Neurology; Vice President, NEINH
The New England Institute for Neurology and Headache, Stamford, CT, United States
Pound Ridge, NY, United States
CL

Christian Lampl, MD, PhD

Konventhospital Barmherzige Brüder Linz, United States
Antoinette Maassen van den Brink, PhD

Associate Professor
Erasmus University Medical Center
Rotterdam, Zuid-Holland, United States
YL

Yingyi Liu, PhD

AbbVie
Chicago, Illinois, United States
EC

Eric Cohen, MD

AbbVie
Chicago, Illinois, United States
KN

Krisztian Nagy, MD, MSc

AbbVie
North Chicago, Illinois, United States
JS

Jonathan H. H. Smith, MD

AbbVie
Chicago, Illinois, United States

B. Lee Peterlin, DO

Medical Director & Founder
Pennsylvania Headache Center
Camp Hill, Pennsylvania, United States